Walter Cox, MD
Obstetrics & Gynecology · Monongahela, PANPI 1093711145
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,483 of the $25,353 with a category attached, or 80.8%. 29 manufacturers reported payments, led by Organon at 40.6% of the total. Reporting peaked in 2024 at $6,276 and has fallen 66.9% since, to $2,079 in 2025. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $138.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$10K
- Applied Medical Resources Corporation$7K
- Merck$5K
- Coloplast$625
- AbbVie$494
- Mayne Pharma Commercial LLC$325
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$20,48381%
- Travel & lodging$1,7677%
- Food & beverage$3,04912%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 32 | $10,303 |
| Applied Medical Resources Corporation | 9 | $7,284 |
| Merck | 18 | $4,890 |
| Coloplast | 4 | $625 |
| AbbVie | 30 | $494 |
| Mayne Pharma Commercial LLC | 17 | $325 |
| Astellas Pharma US Inc | 11 | $247 |
| Amgen | 6 | $124 |
| Therapeuticsmd, Inc. | 7 | $116 |
| Exeltis, USA Inc. | 6 | $114 |
| Bayer | 6 | $107 |
| Agile Therapeutics, Inc. | 4 | $94 |
| Millicent US Inc | 3 | $64 |
| Duchesnay USA Incorporated | 4 | $64 |
| Pfizer | 3 | $58 |
| Cumberland Pharmaceuticals, Inc. | 3 | $55 |
| Boston Scientific | 2 | $54 |
| Integra Lifesciences Corporation | 1 | $48 |
| Exact Sciences | 2 | $38 |
| Coopersurgical, Inc. | 3 | $38 |
| BD | 1 | $36 |
| Minerva Surgical, Inc | 2 | $26 |
| Lupin Inc. | 2 | $26 |
| Avion Pharmaceuticals | 2 | $25 |
| Johnson & Johnson | 1 | $25 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Urovant Sciences Inc | 1 | $18 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$13,002
- GelPOINT V-Path$7,032
- ALTIS$492
How this compares
$25,353 in reported general payments places this provider in the 95th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $10,864 |
| PremproEstrogen,con/M-Progest Acet | 29 | $10,086 |
| PremarinEstrogens, Conjugated | 21 | $6,448 |
| Oxybutynin Chloride ErOxybutynin Chloride | 113 | $2,390 |
| Estradiol | 48 | $2,121 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 43 | $845 |
| Raloxifene Hcl | 14 | $626 |
| Medroxyprogesterone Acetate | 18 | $139 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $65 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPrempro, Premarin | $58 | $16,53450 claims |
| Astellas Pharma US IncMyrbetriq | $247 | $10,86413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Other obstetrics & gynecology in Monongahela
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
- Catherine ChappellPittsburgh$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.